Not One of 51 Analysts Rates Broadcom a Sell — Here's the Catch

All 51 analysts covering Broadcom (NASDAQ:AVGO) rate it a Buy or Hold — not a single Sell — and their consensus price target of $533.42 sits about 49.6% above the $356.54 opening price on November 13, 2026. That level of agreement is itself the story. When an entire research community leans one way, the interesting questions move from whether the numbers are good to what everyone might be pricing wrong.

The setup matters well beyond one stock. Broadcom has become one of the clearest expressions of the custom AI silicon boom, and its results now function as a read on hyperscaler spending. The stock is up only 0.6% year to date, even after an 18.5% one-week run in which Broadcom led S&P 500 gainers amid turmoil at Nvidia (NASDAQ:NVDA), according to MarketWatch. 24/7 Wall St. applied the same consensus-risk framework it previously used on Microsoft and Nvidia.

What are the bulls actually paying for?

The earnings record is the foundation. Broadcom has beaten EPS estimates for nine consecutive quarters. In fiscal Q3, it posted non-GAAP EPS of $3.32 against a $3.24 consensus, and revenue of $29.59 billion beat the $29.44 billion estimate. AI semiconductor revenue rose 221% year over year to $16.70 billion, and Q4 guidance calls for $21.7 billion.

The valuation gives the bulls room too. The stock trades at 18x forward earnings, against 44x trailing. The fiscal 2027 EPS consensus of $19.4651, drawn from 48 analysts, has ticked up from $19.3807 thirty days ago, with two upward revisions and none downward.

High-profile investors have leaned in. On CNBC's Halftime Report on October 27, Stephanie Link said Broadcom guided 2027 revenue to $115 billion, rising to $230 billion by 2028, and that the Anthropic deal secured roughly $60 billion of those 2027 revenues. Jim Cramer said on CNBC on September 15: "Broadcom's view, there will be no slowdown, is the one that is going to take hold of the narrative." On October 28 he added: "I wouldn't shoot Broadcom."

The bull case in one line: the numbers keep beating, and the multiple doesn't look stretched for that growth rate.

What's the bear case no analyst is making?

The sharpest objections come from outside the analyst ranks — from traders and commentators watching deal structures rather than spreadsheets. On the Halftime Report on October 27, Jenny Harrington said: "I think there's a problem when the CEO of Broadcom needs to intervene in the funding of another company." The same day, Cramer asked on CNBC: "What happens when the next deal comes with companies that aren't as good as Broadcom or Anthropic?"

There's also competitive mimicry to watch. On November 2, Joe Terranova described Marvell Technology's (NASDAQ:MRVL) $115 billion all-stock purchase of Lumentum (NASDAQ:LITE) on the Halftime Report this way: "They're chasing Broadcom, in my opinion." When rivals start copying a strategy, the easy gains in that strategy tend to be behind it.

Broadcom's own management has flagged its constraints: land, power, substrates, and HBM memory. And the AI outlook rests on six XPU customers — a concentration that means a single customer's change of plans moves the revenue line.

The market has already shown it will punish the stock even when results are good. Shares fell 12.59% the day after the fiscal Q2 report and 11.43% after fiscal Q4 2025, despite beats in both quarters.

Do unanimous ratings match what the money is doing?

Institutions own 79.7% of shares. But in the latest 13F filings from tracked filers, for the quarter ended September 30, 2026, the only tracked filer — Renaissance Technologies — cut its stake to 734 shares. That's a quarter-end snapshot, not a live position, so it doesn't tell you what anyone holds today. It does suggest the smart-money record here is thinner than the rating wall implies.

Near-term estimates have flattened as well. The fiscal Q4 EPS consensus of $3.8377 is below the $3.8609 of 90 days ago. Technically, the price holds above the 50-day moving average of $346.13 but sits below the 200-day average of $367.12, and a beta of 1.51 signals above-market swings.

The takeaway: ratings say one thing, positioning and price action say something more cautious.

What's the verdict for investors?

On fundamentals, 24/7 Wall St. judges the consensus to be right. Results keep beating estimates, AI revenue is still accelerating, and the forward multiple is modest for that growth rate. The roughly 50% gap between price and target reflects the market pricing in financing and supply risk even while demand signals stay strong.

For readers researching the stock, the job is to weigh the analysts' thesis against the volatility that comes with it. The volatility is not hypothetical — it has shown up on earnings days twice this year.

When does the market get its answer?

The test arrives with the next report, expected around December 10, 2026. Three checks will matter:

• Whether revenue reaches the guided $34.8 billion
• Whether gross margin holds near the guided 73%
• Whether management adds detail on how it supports financing for its AI customers

That last item is the one nobody on the Sell side — because there is nobody on the Sell side — is formally flagging. If Broadcom can show the Anthropic-style funding model scales without the CEO's personal intervention, the unanimous ratings may prove conservative. If it can't, the bears currently working in television studios will have made the call 51 analysts declined to make.